<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content="">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="OP_S7_files/filelist.xml">
<link rel=Edit-Time-Data href="OP_S7_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Bruno Gonçalves</o:Author>
  <o:LastAuthor>Bruno Gonçalves</o:LastAuthor>
  <o:Revision>1</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2016-03-08T21:44:00Z</o:Created>
  <o:LastSaved>2016-03-08T21:44:00Z</o:LastSaved>
  <o:Pages>6</o:Pages>
  <o:Words>2717</o:Words>
  <o:Characters>15490</o:Characters>
  <o:Company>IMM</o:Company>
  <o:Lines>129</o:Lines>
  <o:Paragraphs>36</o:Paragraphs>
  <o:CharactersWithSpaces>18171</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="OP_S7_files/themedata.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Arial;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Arial;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:"Lucida Grande";
	panose-1:2 11 6 0 4 5 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-520090897 1342218751 0 0 447 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:Arial;
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:DE-CH;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:DE-CH;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:PT;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-ascii-font-family:"Lucida Grande";
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:"Lucida Grande";
	mso-bidi-font-family:"Lucida Grande";
	mso-ansi-language:DE-CH;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:595.0pt 842.0pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]-->
</head>

<body bgcolor=white lang=EN-US style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:10.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP39
- Targeted Metagenomics To Track And Characterize The Antimicrobial Resistome
(RESCAP1.0)<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span lang=DE-CH style='mso-bidi-font-size:9.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-fareast-language:PT'>Val Fernandez Lanza</span></u><sup><span
lang=DE-CH style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>1</span></sup><span
lang=DE-CH style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>; Irene
Rodriguez<sup>2</sup>; Ana P. Tedim<sup>2</sup>; Maria de Toro<sup>3</sup>;
Fernando de la Cruz<sup>3</sup>; Rafael Cantón<sup>2</sup>; Fernando Baquero<sup>2</sup>;
Teresa M. Coque<sup>2</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span lang=DE-CH
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span lang=DE-CH style='mso-bidi-font-size:
9.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-fareast-language:PT'>Instituto Ramon y Cajal de Investigaciones
Sanitarias; <sup>2</sup>CIBER-ESP. </span></i><i style='mso-bidi-font-style:
normal'><span lang=PT style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
PT;mso-fareast-language:PT'>Hospital Universitario Ramón y Cajal and Instituto
Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, Spain; <sup>3</sup>Instituto
de Biomedicina y Biotecnología de Cantabria IBBTEC UC-SODERCAN-CSIC, Santander,
Spain<o:p></o:p></span></i></p>

<p class=MsoNormal><span lang=PT style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:6.0pt;text-align:left'><b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Background: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>Metagenomics has recently been used to analyze
the ensemble of antimicrobial resistance genes in a particular environment
(resistome). All metagenomic open and closed formats exhibit low sensitivity
and lack of specificity to uncover the size and diversity of minor fractions of
total metagenomes. To achieve better sensitivity and specificity in resistome
mining, we developed a targeted sequence capture panel (ResCap v.01) based on
SeqCapEZ technology (NimblegeneRoche), designed to enrich sequences from genes
encoding resistance to antibiotics, biocides and heavy metals.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:6.0pt;text-align:left'><span
class=GramE><b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>Material &amp; Methods: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>ResCap is composed by a panel of approximately 79,000 non-redundant genes
(80 Mb) including 7,963 well-known antibiotic resistance genes, 30,740 biocide
&amp; heavy metal resistance genes, and 2,517 relaxases, signature proteins of
plasmid conjugation</span></span><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>. Design of the
probes was based on a non-redundant database (DB), constructed by mixing
curated DBs for antibiotic resistance (CARD, ARG-ANNOT and RED-DB). To improve
the detection of “novel” AbR genes, a Hidden Markov Model (HMM) from each AbR
family was constructed for detection of homologous sequences by using hammer3
software against Uniref100 DB. Sequences coding for resistance to heavy metals
and antiseptics were recruited from BacMet DB, which includes both
experimentally confirmed and predicted antibacterial biocide- and
metal-resistance genes. Relaxases were retrieved from the ConjDB repository.
ResCap workflow consisted on i) whole-metagenome shotgun library construction,
ii) hybridization, and iii) capture. All steps were performed according
Nimblegene standard protocols for Illumina platforms. To evaluate ResCap
efficiency, samples were sequenced before and after capture. ResCap was
validated by analysing fecal samples from 9 humans and 8 swine. Robustness of
the platform was tested by comparative analysis of two technical replicates of
two samples. Bioinformatic analysis was performed by mapping sequenced reads
against well-known gene DBs (ARG-ANNOT<span class=GramE>,BacMet</span>
Experimental and ConjDB) using Bowtie2 with the output option of all hits (-a).
All statistical operations were performed using R and homemade Perl scripts.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:6.0pt;text-align:left'><b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Results: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>An average of 1.9x10<sup>7</sup> reads were obtained
from the ResCap pool (9,2-32 10<sup>6</sup>). The average on-target hits was
0,11% (0,07%-0<span class=GramE>.18</span>%) for pre-captured samples and 30%
(20%-41%) for post-captured sequences. The enhanced sensitivity of ResCap
represents a gain of 279 fold (170-480 fold). The diversity of genes encoding
antimicrobial resistance and relaxases was 627 (436-937) in pre-capture samples
and 1367 (1071-1616) in samples captured with ResCap (Figure 1).
Reproducibility was addressed by the correlation between replicates, showing R
factors of 0.81 and 0.96, respectively.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:6.0pt;text-align:left'><b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Conclusion: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>ResCap v0.1 substantially enhances the
sensitivity and specificity of metagenomics shotgun sequencing for analyzing
the resistome. Moreover, the ability to accurately detect low abundant or rare
populations and its robustness, make ResCap a promising tool for a wide number
of research and diagnostic applications and suitable for being used in both
longitudinal and cross-sectional studies The platform constitutes one of the
first examples of targeted metagenomics for analysing bacterial populations.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span style='font-size:8.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;mso-ansi-language:EN-US;
mso-no-proof:yes'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Imagem_x0020_14" o:spid="_x0000_i1025" type="#_x0000_t75"
 alt="Description: https://www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/154imagem_2560108707_0.jpg"
 style='width:333pt;height:213pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="OP_S7_files/image001.jpg" o:title="//www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/154imagem_2560108707_0.jpg"/>
</v:shape><![endif]--><![if !vml]><img width=335 height=215
src="public/abstracts/Webpages/OP_S7_files/image002.png"
alt="Description: https://www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/154imagem_2560108707_0.jpg"
v:shapes="Imagem_x0020_14"><![endif]></span><span lang=EN-GB style='mso-bidi-font-family:
Arial;color:black;mso-themecolor:text1;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Figure 1. Boxplot
of metagenomic diversity of samples pre-captured and targeted captured with
ResCap</span><span lang=EN-GB style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<span lang=EN-GB style='font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:
115%;font-family:Arial;mso-fareast-font-family:Cambria;mso-fareast-theme-font:
minor-latin;color:black;mso-themecolor:text1;mso-ansi-language:EN-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='mso-bidi-font-family:Arial;
color:black;mso-themecolor:text1;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP40
- A Pilot Study Using WGS To Detect The Prevalence And Mechanism Of
Azithromycin Resistance In A U.K Population Of Non Typhoidal <i
style='mso-bidi-font-style:normal'>Salmonella</i><span style='text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Satheesh Nair</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Philip Ashton<sup>1</sup>; Gauri Godbole<sup>1</sup>;
Michel Doumith<sup>1</sup>; Steve Connell<sup>1</sup>; Anais Painset<sup>1</sup>;
Elizabeth de Pinna<sup>1</sup>; Martin Day<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>Public Health England<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left'><span lang=EN-GB
style='mso-bidi-font-family:Arial;color:black;mso-themecolor:text1;mso-ansi-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Background: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>Multidrug resistance especially to first line <span
class=GramE>antibiotics ,fluoroquinolones</span> and 3<sup>rd</sup> generation
cephalosporins in <i>Salmonella</i> are an emerging threat. Resistance to
azithromycin has also been described recently in the Enterobacteriaceae
population. Whole genome sequencing (WGS) and phenotypic methods were used in
this study to determine the prevalence of azithromycin resistance in <i>Salmonella
enterica</i> isolates from the UK and identify the underlying mechanisms of
resistance.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Methods: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>WGS by Illumina HiSeq was carried out on 683
isolates of <i>Salmonella</i> spp isolated between 2012-2015 from the
Gastrointestinal Bacteria Reference Unit (GBRU), Public Health England (PHE).
Detection of known acquired resistance genes, including those previously
associated with azithromycin resistance were determined from WGS using a
mapping-based approach and presence of those encoding </span><span lang=DE-CH
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-fareast-language:PT'>β</span><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>-lactamases
were confirmed by PCR. Characterization and location of macrolide/azalide
resistant determinants were assessed by BANDAGE, BLAST and ARTEMIS genome
browser analysis. Susceptibility testing was in accordance with the EUCAST
methodology (MIC breakpoint ≤16mg/L).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Results: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>Nine isolates of non-typhoidal <i>Salmonella
enterica</i> (NTS) belonging to serovars <i>S</i>.Blockley, <i>S</i>.
Typhimurium, <i>S</i>. Thompson, <i>S</i>. Ridge and <i>S</i>. Kentucky showed
resistance or decreased susceptibility to azithromycin (from 6 to &gt;16mg/L)
due to the presence of macrolide resistance <span class=GramE>genes &nbsp;<i>mph</i>A</span>,
<i>mph</i>B or <i>mef</i>B. These genes are either plasmid or chromosomally
mediated. None of the isolates had the <i>erm</i>B gene associated with
resistance to Erythromycin. All nine isolates were also resistant to multiple
classes of antibiotics, including ampicillin, aminoglycosides, trimethoprim,
tetracycline, sulphonamide ciprofloxacin and third generation cephalosporins.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Characterisation
of a further 16 <i>S</i>. Blockley isolates showed the presence of <i>mph</i>A
in six unrelated isolates. All nine <i>S</i>. Blockley isolates harbour the
macrolide inactivation gene cluster <i>mph</i>A-<i>mrx</i>-<span class=GramE><i>mph</i>r(</span>A)&nbsp;
in the same chromosomal location.To our knowledge this is the first novel
chromosomally mediated <i>mph</i>A gene cluster in Salmonellae. Phylogenetic
analysis based on single nucleotide polymorphisms (SNP) of all the <i>S</i>.
Blockley isolates indicated that <i>S</i>. Blockley isolates harbouring <i>mph</i>A
gene formed a single lineage, distinct from <i>S</i>. Blockley’s without the <i>mph</i>A
gene.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>The
azithromycin MICs of the 15 <span class=GramE><i>Salmonella</i>&nbsp; spp</span>.
isolates showed that the presence of the <i>mph</i>A gene was associated with
MIC≥16mg/L, while presence of <i>mef </i>B or <i>mph </i>B was not associated
with MIC≥16 mg/L.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Conclusion: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>The study showed that resistance to
azithromycin, entirely due to acquisition of known macrolide resistance genes
was seen in four different <i>Salmonella</i> serovars and can be either plasmid
or chromosomal encoded. Even though the numbers of azithromycin resistance in <i>Salmonella</i>
spp. from the UK remained low (15/683 isolates studied) this does not rule out
the possibility of spread or increase of azithromycin resistance in the future
and in turn requires the re-evaluation of azithromycin treatment for Salmonellosis.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP41
- Molecular Epidemiology Of Carbapenemase-Producing Gram-Negatives In A
Pediatric Hospital In Angola<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span lang=DE-CH style='mso-bidi-font-size:9.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-fareast-language:PT'>Laurent Poirel </span></u><sup><span
lang=DE-CH style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>1</span></sup><span
lang=DE-CH style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>; Nicolas Kieffer<sup>
1</sup>; Marta Aires-De-Sousa <sup>2</sup>; Patrice Nordmann<sup> 1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span lang=DE-CH
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span lang=DE-CH style='mso-bidi-font-size:
9.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-fareast-language:PT'>University of Fribourg; <sup>2</sup>Escola
Superior de Saúde da Cruz Vermelha Portuguesa<o:p></o:p></span></i></p>

<p class=MsoNormal><span lang=DE-CH style='mso-bidi-font-family:Arial;
color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Acquired resistance to carbapenems in Gram negatives nowadays represents a
major public health threat. Resistance to carbapenems is mainly due to
production of acquired carbapenemases. The class B carbapenemase NDM-1 and the
class D carbapenemase OXA-48 are increasingly identified worldwide, being
mostly found in Enterobacteriaceae. No epidemiological data are available
regarding the occurrence of carbapanemases in Angola. We therefore initiated a
prospective study in order to evaluate the rate of colonization of patients by
carbapenemase producers at a Pediatric hospital in Luanda.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Rectal swabs were collected from children being either inpatients or
outpatients during a one-week screening period, May 2015. After a
pre-enrichement in broth supplemented with ertapenem 0.25 µg/ml, samples were
screened for the occurrence of carbapenem-resistant enterobacterial isolates
using selective agar plates including the Chrom ID Carba SMART (bioMérieux).
Then colonies were tested with the Rapidec Carba NP test (bioMérieux) for
detection of carbapenemase production. PCR experiments were further performed
using primers specific for all&nbsp;carbapenemase genes (KPC, NDM and
OXA-48-like).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conjugation
experiments were realized by broth mating method in order to detect the
possible transfer of the carbapenemase genes. Genotyping was performed by PFGE
analysis and also by MLST.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> A total of 157 samples were collected from children being 3 months to 13 <span
class=GramE>years-old</span>. A total of 90&nbsp;carbapenem-resistant <span
class=GramE>Gram negative</span> isolates were recovered, the majority being <i>Klebsiella
pneumoniae </i>(n=34) and <i>Escherichia coli </i>(n=37) isolates. A total of
74 carbapenemase producers were identified, including 34 <i>K. pneumoniae</i>,
33 <i>E. coli,</i> and 4 <i>Acinetobacter baumannii.</i> The most common
carbapenemase identified was OXA-181 (a derivative of OXA-48) found in 39 32 <i>K.
pneumoniae</i>, 29 <i>E. coli</i>, and a single <i>Enterobacter cloacae</i>.
Nine NDM-1-producing isolates were identified, being 4 <i>E. coli</i>, 2 <i>K.
pneumoniae</i>, a single <i>Providencia stuartii</i>, a single <i>Providencia
retgeri</i>, and a single <i>A. baumannii</i>. PFGE analysis indicated that
eleven different clones were identified among the 32 <i>K. pneumoniae</i>
isolates. Seventeen different clones were identified among the 31 <i>E. coli</i>
isolates. MLST indicated that <span class=GramE>Among the <i>E. coli</i></span>
isolates, the most frequent Sequence Type was ST5692. Among the <i>K.
pneumoniae</i> isolates, the most frequent Sequence Type was a new ST.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> This study identified for the first time carbapenemase producers in
Angola. Noteworthy, those isolates were recovered from children. There <span
class=GramE>was</span> a significant number of NDM-1 producers, there was a
large majority of OXA-181-producing isolates. This is remarkably considering
that so far there have been only scattered reports of OXA-181 producers in the
world, even though the Indian subcontinent is supposed to be the main reservoir
nowadays, as it is for NDM-1 producers. The source of contamination could not be
linked to India so far, and therefore remains unknown. According to the very
high rate of carbapenemase-producing isolates identified here, it seems that
Angola can be now considered as an endemic area.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:10.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP42
- Investigation Of Potential Sharing Of Carbapenem Resistance Plasmids Between
Members Of The Enterobacteriaceae Using MinION Technology<span
style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Sandra Reuter</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Kim Judge<sup>1</sup>; Simon R Harris<sup>2</sup>;
Catherine Ludden<sup>1</sup>; Theodore Gouiouris<sup>1</sup>; Sharon J Peacock<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>University of Cambridge; <sup>2</sup>Wellcome Trust Sanger Institute<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>This abstract presents independent research
supported by the Health Innovation Challenge Fund (WT098600, HICF-T5-342), a
parallel funding partnership between the Department of Health and Wellcome
Trust.<o:p></o:p></span></p>

<p class=MsoNormal><span lang=DE-CH style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-fareast-language:
PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>Keywords</span><span lang=DE-CH
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-fareast-language:PT'>: Carbapenem resistance, plasmids,
MinION</span><span style='mso-bidi-font-family:Arial;color:black;mso-themecolor:
text1;mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Carbapenem resistance in Enterobacteriaceae is increasing worldwide,
leading to limited treatment options. This resistance may arise through
different mechanisms, the most worrying being the acquired carbapenemases
transferrable via mobile genetic elements such as plasmids. During
investigations of wastewater in East Anglia, England, two carbapenem resistant
isolates (one <i>Raoultella ornithinolytica</i>, one <i>Enterobacter kobei</i>)
were recovered that shared a similar phenotypic resistance pattern and with the
same carbapenemase gene. We sought to investigate the potential sharing of
plasmids between these isolates.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Untreated wastewater was obtained from a treatment plant in East Anglia.
Carbapenem-resistant Enterobacteriaeceae were identified using MALDI-TOF mass
spectometry, and minimum inhibitory concentrations to meropenem, ertapenem, and
<span class=GramE>imipenem were determined by the Etest</span>. We undertook
sequencing using a combination of Illumina and MinION technology to address the
technical challenge of assembling short reads associated with regions of
repeats and insertion sequence elements. We aimed to scaffold the bacterial
genomes in as few contigs as possible, and obtain single-contig plasmids.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Single technology assemblies were performed for Illumina and the MinION
data, and compared with hybrid assembly. Shared plasmids were not detectable
using the Illumina data alone, but analysis confirmed the presence of plasmids
in both bacterial isolates contributing to the antimicrobial resistance observed.
Betalactamase genes found in both isolates were <i>bla</i><sub>OXA-48</sub>
conferring carbapenem resistance, <i>bla</i><sub>SHV-12</sub> for an
extended-spectrum betalactamase (ESBL) phenotype, and <i>bla</i><sub>TEM-1</sub>.
Resistance to other antimicrobial resistance classes were also detected, including
aminoglycosides (<i>aac</i>6’-IIc), erythromycin (<i>ereA2</i>), sulphonamide (<i>sul1</i>),
as well as heavy metal resistance (arsenic, copper, tellurite, mercury,
cadmium).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>The dissemination of carbapenemase genes in wasterwater is an important
public health concern. As carbapenemases can be spread via plasmids between
organisms, it is imperative that suitable methods are developed for detection
of such plasmids in order to fully investigate the global epidemiology.
Plasmids and their dissemination through different bacterial species is
difficult to track using short-read data, with long-read options such as MinION
opening new investigation avenues, either using a hybrid or long-read only
assembly approach.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>This
abstract presents independent research supported by the Health Innovation
Challenge Fund (WT098600, HICF-T5-342), a parallel funding partnership between
the Department of Health and Wellcome Trust.<o:p></o:p></span></p>

<span lang=DE-CH style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:DE-CH;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=DE-CH style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP43
- Genomic Epidemiology Of Vancomycin Resistant <i style='mso-bidi-font-style:
normal'>Enterococcus faecium</i> And Dissemination Of The VanA Transposon
(Tn1546) In Copenhagen 2012-14<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Mette Pinholt</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Jesper Boye Nielsen<sup>1</sup>; Heidi Gumpert<sup>1</sup>;
Michael Pedersen<sup>2</sup>; Veronika Vorobieva<sup>3</sup>; Peder Worning<sup>1</sup>;
Henrik Westh<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>Department of Clinical Microbiology, Hvidovre University Hospital; <sup>2</sup>Department
of Clinical Microbiology, Herlev University Hospital; <sup>3</sup>Department of
Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=DE-CH style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-fareast-language:
PT;mso-bidi-font-weight:bold'>Keywords: </span><span lang=DE-CH
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-fareast-language:PT'>VRE, whole genome sequencing, Tn1546
transposon<b><o:p></o:p></b></span></p>

<p class=MsoNormal><b><span lang=DE-CH style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-fareast-language:
PT'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Vancomycin resistant <i>Enterococcus faecium</i> (VREfm) is an emergent
nosocomial problem. From&nbsp;2012 - 2014&nbsp;a ten-fold increase of <i>vanA</i>
VREfm isolates was observed in Copenhagen. <i>E. <span class=GramE>faecium</span></i>
is inherently resistant to cephalosporins and has the capacity to acquire and
disseminate mobile genetic elements containing virulence and resistance genes.
The <i>vanA</i> transposon (Tn1546) consists of two transfer-related genes (<i>orf1
</i>and<i> orf2</i>), two regulatory genes (<i>vanR </i>and<i> vanS</i>), four
vancomycin resistance genes (<i>vanH, vanA, vanX </i>and<i> vanY</i>) and a <i>vanZ
</i>gene of unknown function. Variations in the Tn1546 transposon structure
among clinical VREfm isolates are well described. The objective of this study
was to determine the clonal structure of the <i>vanA</i> VREfm isolates in
Copenhagen. Furthermore, all <i>vanA</i> transposons have been characterised to
assess their similarity.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>All <i>vanA </i>VREfm from Copenhagen (The Capital Region of Denmark, 1.7 M
inhabitants) submitted to Hvidovre University Hospital from January 2012
through December 2014 for whole genome sequencing were included in the study.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>All isolates
were sequenced on the Illumina MiSeq platform. 2 x 150 bp paired-end reads were
produced. Reads were mapped with Stampy to AUS004 (NC-017022). SNP calling was
performed using Samtools. <span class=GramE>Phylogeny was inferred by the
neighbor-joining algorithm</span> with bootstrapping in SplitsTree4. Sequence
reads were assembled <i>de novo</i> using Velvet. All isolates were annotated
by RAST to determine the presence and location of <i>orf1</i>-<i>orf2</i>, <i>van</i>
genes and IS elements. Multiple alignments of transposon&nbsp;elements were
performed by Muscle to identify point mutations and deletions in genes and
intergenic regions.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Four hundred and ninety five <i>vanA</i> VREfm isolates were whole genome
sequenced. The SNP-tree revealed a picture of genetic diversity where&nbsp;the
isolates were divided into 19 distinct groups and 25 singletons. Using a
similarity threshold of ≤4&nbsp;SNPs demonstrated that many VREfm isolates were
genetically closely related. A total of 412 (83%) VREfm isolates differed by&nbsp;≤4&nbsp;SNPs
to at least one VREfm isolate and 318 (64%) differed by&nbsp;≤4&nbsp;SNPs to at
least five VREfm isolates.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Four
different transposon structures were identified. The dominant Tn1546-like
transposon (81%) had a deletion of <i>orf1 </i>and an insertion of a
transposase IS<i>1251</i> in the intergenic region between <i>vanS</i> and <i>vanH</i>.
Eleven percent had a similar structure including a deletion of <i>orf2</i>. The
original Tn1546 structure was present in 4% of the isolates and another 4% had
a deletion of <i>orf1 </i>and <i>orf2</i>. Multiple alignments demonstrated that
the transposon elements were highly conserved. Only two positions in the
transposon were affected by point mutations. Both mutations were
non-synonymous&nbsp;and they only affected a single codon.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Genomic epidemiology&nbsp;has revealed a polyclonal structure of the VREfm
isolates. However, within the groups the isolates are genetically closely
related. The majority of the isolates harbour an identical Tn1546-like
transposon. This suggests that dissemination of the Tn1546-like transposon by
horizontal transfer into ampicillin resistant, vancomycin susceptible <i>E.
faecium</i>, followed by clonal spread of VREfm in the hospitals have
contributed to the increase and diversity of VREfm in Copenhagen.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:10.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>SC06
- Genomic Epidemiology Of Vancomycin-Resistant <i style='mso-bidi-font-style:
normal'>Enterococcus faecium</i> (VRE) During An Epidemic Rise Of VRE In Dutch
Hospitals<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNoSpacing style='text-align:justify;text-justify:inter-ideograph'><span
style='font-size:10.0pt;font-family:Arial;color:black;mso-ansi-language:EN-US'>Malbert
Rogers<sup>1; </sup>Anita Schürch<sup>1</sup>; Iris Braat<sup>1</sup>; Ellen
Brouwer<sup>1</sup>; Janetta Top<sup>1</sup>; Marc Bonten<sup>1</sup>; Jukka
Corander<sup>2</sup>; <u>Rob Willems</u><sup>1</sup></span><b><span
style='font-size:10.0pt;font-family:Arial;mso-fareast-font-family:"Times New Roman";
color:gray;mso-ansi-language:EN-US;mso-fareast-language:PT'><o:p></o:p></span></b></p>

<p class=MsoNormal><sup><span style='mso-bidi-font-size:10.0pt;mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-US'>1</span></sup><span
style='mso-bidi-font-size:10.0pt;mso-bidi-font-family:Arial;color:black;
mso-ansi-language:EN-US'>UMC Utrecht; <sup>2</sup>University of Helsinki</span><span
lang=EN-GB style='mso-bidi-font-size:10.0pt;mso-bidi-font-family:Arial;
color:black;mso-themecolor:text1;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=DE-CH><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
